153 related articles for article (PubMed ID: 17645641)
1. Interplay of reactive oxygen species and nitric oxide in the pathogenesis of experimental lead-induced hypertension.
Vaziri ND; Khan M
Clin Exp Pharmacol Physiol; 2007 Sep; 34(9):920-5. PubMed ID: 17645641
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension.
Schulz E; Jansen T; Wenzel P; Daiber A; Münzel T
Antioxid Redox Signal; 2008 Jun; 10(6):1115-26. PubMed ID: 18321209
[TBL] [Abstract][Full Text] [Related]
3. Smooth muscle-specific deletion of nitric oxide-sensitive guanylyl cyclase is sufficient to induce hypertension in mice.
Groneberg D; König P; Wirth A; Offermanns S; Koesling D; Friebe A
Circulation; 2010 Jan; 121(3):401-9. PubMed ID: 20065162
[TBL] [Abstract][Full Text] [Related]
4. Effect of renal injury-induced neurogenic hypertension on NO synthase, caveolin-1, AKt, calmodulin and soluble guanylate cyclase expressions in the kidney.
Bai Y; Ye S; Mortazavi R; Campese V; Vaziri ND
Am J Physiol Renal Physiol; 2007 Mar; 292(3):F974-80. PubMed ID: 17122386
[TBL] [Abstract][Full Text] [Related]
5. Nitric oxide-independent stimulation of soluble guanylate cyclase with BAY 41-2272 in cardiovascular disease.
Boerrigter G; Burnett JC
Cardiovasc Drug Rev; 2007; 25(1):30-45. PubMed ID: 17445086
[TBL] [Abstract][Full Text] [Related]
6. Tempol-nebivolol therapy potentiates hypotensive effect increasing NO bioavailability and signaling pathway.
Bertera FM; Santa-Cruz DM; Balestrasse KB; Gorzalczany SB; Höcht C; Taira CA; Polizio AH
Free Radic Res; 2014 Feb; 48(2):109-18. PubMed ID: 24074298
[TBL] [Abstract][Full Text] [Related]
7. Gender-specific hypertension and responsiveness to nitric oxide in sGCalpha1 knockout mice.
Buys ES; Sips P; Vermeersch P; Raher MJ; Rogge E; Ichinose F; Dewerchin M; Bloch KD; Janssens S; Brouckaert P
Cardiovasc Res; 2008 Jul; 79(1):179-86. PubMed ID: 18339647
[TBL] [Abstract][Full Text] [Related]
8. Regulation of the expression of soluble guanylyl cyclase by reactive oxygen species.
Gerassimou C; Kotanidou A; Zhou Z; Simoes DC; Roussos C; Papapetropoulos A
Br J Pharmacol; 2007 Apr; 150(8):1084-91. PubMed ID: 17339839
[TBL] [Abstract][Full Text] [Related]
9. Shattuck Lecture. Nitric oxide and cyclic GMP in cell signaling and drug development.
Murad F
N Engl J Med; 2006 Nov; 355(19):2003-11. PubMed ID: 17093251
[No Abstract] [Full Text] [Related]
10. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
Sharkovska Y; Kalk P; Lawrenz B; Godes M; Hoffmann LS; Wellkisch K; Geschka S; Relle K; Hocher B; Stasch JP
J Hypertens; 2010 Aug; 28(8):1666-75. PubMed ID: 20613628
[TBL] [Abstract][Full Text] [Related]
11. [Nitric oxide and shear stress].
Ando J; Yamamoto K; Korenaga R
Nihon Rinsho; 2004 Sep; 62 Suppl 9():478-82. PubMed ID: 15506431
[No Abstract] [Full Text] [Related]
12. Soluble guanylate cyclase-alpha1 deficiency selectively inhibits the pulmonary vasodilator response to nitric oxide and increases the pulmonary vascular remodeling response to chronic hypoxia.
Vermeersch P; Buys E; Pokreisz P; Marsboom G; Ichinose F; Sips P; Pellens M; Gillijns H; Swinnen M; Graveline A; Collen D; Dewerchin M; Brouckaert P; Bloch KD; Janssens S
Circulation; 2007 Aug; 116(8):936-43. PubMed ID: 17679618
[TBL] [Abstract][Full Text] [Related]
13. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
[TBL] [Abstract][Full Text] [Related]
14. In vivo exposure to carbon monoxide causes delayed impairment of activation of soluble guanylate cyclase by nitric oxide in rat brain cortex and cerebellum.
Hernández-Viadel M; Castoldi AF; Coccini T; Manzo L; Erceg S; Felipo V
J Neurochem; 2004 Jun; 89(5):1157-65. PubMed ID: 15147508
[TBL] [Abstract][Full Text] [Related]
15. Translating the oxidative stress hypothesis into the clinic: NOX versus NOS.
Armitage ME; Wingler K; Schmidt HH; La M
J Mol Med (Berl); 2009 Nov; 87(11):1071-6. PubMed ID: 19834654
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of nitric oxide production].
Ayajiki K; Shinozaki K; Okamura T
Nihon Rinsho; 2004 Sep; 62 Suppl 9():446-50. PubMed ID: 15506424
[No Abstract] [Full Text] [Related]
17. Altered guanylyl-cyclase activity in vitro of pulmonary arteries from fetal lambs with congenital diaphragmatic hernia.
Thébaud B; Petit T; De Lagausie P; Dall'Ava-Santucci J; Mercier JC; Dinh-Xuan AT
Am J Respir Cell Mol Biol; 2002 Jul; 27(1):42-7. PubMed ID: 12091244
[TBL] [Abstract][Full Text] [Related]
18. Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension.
Oka M; Karoor V; Homma N; Nagaoka T; Sakao E; Golembeski SM; Limbird J; Imamura M; Gebb SA; Fagan KA; McMurtry IF
Cardiovasc Res; 2007 Jun; 74(3):377-87. PubMed ID: 17346686
[TBL] [Abstract][Full Text] [Related]
19. [Role of nitric oxide/cGMP system in platelet function].
Inoue N
Nihon Rinsho; 2004 Sep; 62 Suppl 9():500-4. PubMed ID: 15506436
[No Abstract] [Full Text] [Related]
20. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
